PNPLA3 and Cirrhosis: A longitudinal study assessing the impact of genetic polymorphisms on outcomes in patients with T2DM and MASLD who were positive for PNPLA3 and TM6SF2 risk alleles (combined polymorphism analysis) demonstrated an even higher risk of cirrhosis if two or more risk alleles were present (odds ratio [OR] 18.48).